Respuestas clínicas Cochrane
Las Respuestas Clínicas de la Cochrane (CCA) proporcionan un punto de entrada legible, sencillo y con enfoque clínico a la investigación rigurosa de las revisiones sistemáticas de la Cochrane. Están diseñadas para ser procesables e informar sobre la toma de decisiones en el punto de atención médica y se han añadido a las secciones pertinentes del texto principal de las Best Practice.
- What are the effects of interventions to improve inhaler technique in children with asthma?
- In children with chronic asthma, what are the benefits and harms of adding long-acting beta2-agonists compared with adding anti-leukotrienes to inhaled corticosteroids?
- How do anti-leukotriene agents compare with inhaled corticosteroids in the management of recurrent and/or chronic asthma in children?
- How does ciclesonide compare with other inhaled corticosteroids in children and adolescents with chronic asthma?
- What adverse events are associated with formoterol when used for the regular treatment of chronic asthma?
- What are the benefits and harms of adding anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma?
- For children with asthma, can exhaled nitric oxide levels help to guide treatment?
- What are the benefits and harms of home telemonitoring and remote feedback between clinic visits in people with asthma?
- What are the effects of school‐based interventions for children and adolescents with asthma?
- Does asthma education for school staff benefit children with asthma?
- In people with mild to moderate asthma, how do flu vaccines affect asthma symptoms?
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad